181 related articles for article (PubMed ID: 15513926)
41. RhoA and a cytosolic 50-kDa factor reconstitute GTP gamma S-dependent phospholipase D activity in human neutrophil subcellular fractions.
Kwak JY; Lopez I; Uhlinger DJ; Ryu SH; Lambeth JD
J Biol Chem; 1995 Nov; 270(45):27093-8. PubMed ID: 7592961
[TBL] [Abstract][Full Text] [Related]
42. RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.
Yu J; Zhang D; Liu J; Li J; Yu Y; Wu XR; Huang C
J Biol Chem; 2012 Apr; 287(17):13752-60. PubMed ID: 22393046
[TBL] [Abstract][Full Text] [Related]
43. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity.
Gorvel JP; Chang TC; Boretto J; Azuma T; Chavrier P
FEBS Lett; 1998 Jan; 422(2):269-73. PubMed ID: 9490022
[TBL] [Abstract][Full Text] [Related]
44. Functional analysis of RhoGDI inhibitory activity on vacuole membrane fusion.
Logan MR; Jones L; Forsberg D; Bodman A; Baier A; Eitzen G
Biochem J; 2011 Mar; 434(3):445-57. PubMed ID: 21171963
[TBL] [Abstract][Full Text] [Related]
45. Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor.
Kweon SM; Cho YJ; Minoo P; Groffen J; Heisterkamp N
J Biol Chem; 2008 Feb; 283(6):3023-3030. PubMed ID: 18070886
[TBL] [Abstract][Full Text] [Related]
46. Rho GDP dissociation inhibitor alpha interacts with estrogen receptor alpha and influences estrogen responsiveness.
El Marzouk S; Schultz-Norton JR; Likhite VS; McLeod IX; Yates JR; Nardulli AM
J Mol Endocrinol; 2007 Oct; 39(4):249-59. PubMed ID: 17909265
[TBL] [Abstract][Full Text] [Related]
47. Negative charges in the flexible N-terminal domain of Rho GDP-dissociation inhibitors (RhoGDIs) regulate the targeting of the RhoGDI-Rac1 complex to membranes.
Ueyama T; Son J; Kobayashi T; Hamada T; Nakamura T; Sakaguchi H; Shirafuji T; Saito N
J Immunol; 2013 Sep; 191(5):2560-9. PubMed ID: 23918979
[TBL] [Abstract][Full Text] [Related]
48. A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm.
Keep NH; Barnes M; Barsukov I; Badii R; Lian LY; Segal AW; Moody PC; Roberts GC
Structure; 1997 May; 5(5):623-33. PubMed ID: 9195882
[TBL] [Abstract][Full Text] [Related]
49. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP.
Rotblat B; Niv H; André S; Kaltner H; Gabius HJ; Kloog Y
Cancer Res; 2004 May; 64(9):3112-8. PubMed ID: 15126348
[TBL] [Abstract][Full Text] [Related]
50. RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas.
Adra CN; Manor D; Ko JL; Zhu S; Horiuchi T; Van Aelst L; Cerione RA; Lim B
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4279-84. PubMed ID: 9113980
[TBL] [Abstract][Full Text] [Related]
51. Activation of NADPH oxidase involves the dissociation of p21rac from its inhibitory GDP/GTP exchange protein (rhoGDI) followed by its translocation to the plasma membrane.
Abo A; Webb MR; Grogan A; Segal AW
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):585-91. PubMed ID: 8141770
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex.
Di-Poï N; Fauré J; Grizot S; Molnár G; Pick E; Dagher MC
Biochemistry; 2001 Aug; 40(34):10014-22. PubMed ID: 11513579
[TBL] [Abstract][Full Text] [Related]
53. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
54. Crystallization and preliminary crystallographic studies of RhoGDI in complex with the radixin FERM domain.
Hamada K; Seto A; Shimizu T; Matsui T; Takai Y; Tsukita S; Tsukita S; Hakoshima T
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):889-90. PubMed ID: 11375519
[TBL] [Abstract][Full Text] [Related]
55. Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions.
Bilodeau D; Lamy S; Desrosiers RR; Gingras D; Béliveau R
Biochem Cell Biol; 1999; 77(1):59-69. PubMed ID: 10426287
[TBL] [Abstract][Full Text] [Related]
56. Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling.
Matos P; Collard JG; Jordan P
J Biol Chem; 2003 Dec; 278(50):50442-8. PubMed ID: 14506233
[TBL] [Abstract][Full Text] [Related]
57. RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs.
Gorovoy M; Neamu R; Niu J; Vogel S; Predescu D; Miyoshi J; Takai Y; Kini V; Mehta D; Malik AB; Voyno-Yasenetskaya T
Circ Res; 2007 Jul; 101(1):50-8. PubMed ID: 17525371
[TBL] [Abstract][Full Text] [Related]
58. RhoGDI signaling provides targets for cancer therapy.
Harding MA; Theodorescu D
Eur J Cancer; 2010 May; 46(7):1252-9. PubMed ID: 20347589
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of RhoGDI by p21-activated kinase 1.
DerMardirossian CM; Bokoch GM
Methods Enzymol; 2006; 406():80-90. PubMed ID: 16472651
[TBL] [Abstract][Full Text] [Related]
60. Serum-activated assembly and membrane translocation of an endogenous Rac1:effector complex.
Hansen MD; Nelson WJ
Curr Biol; 2001 Mar; 11(5):356-60. PubMed ID: 11267873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
